Left Atrial Appendage Occlusion: Clinical Outcomes according to Device Implantation Depth

Continuous improvement of left atrial appendage occlusion (LAAO) devices has had a positive impact on the safety and efficacy of this technique. However, device related thrombus formation (DRT) is still a major concern because of the associated increased risk of thromboembolic events. Approaching this complication calls for more intense antithrombotic treatments, which in turn involves a higher risk of bleeding. 

Cierre de orejuela de aurícula izquierda: Resultados clínicos según la profundidad del implante del dispositivo

Multiple clinical, anatomical and procedural factors have been shown to increase the risk of DRT. Among the procedural factors, we find implantation depth. However, data on this aspect are limited to small studies and the differences between devices remains unclear. 

The aim of this retrospective and multicenter study was to assess the role of implantation depth in the formation of DRT. 

Primary end point was device implantation depth (proximal or distal) impact on DRT incidence. Secondary end point focused on DRT incidence relative to implantation area or angle between pulmonary vein crest and device surface. In addition, clinical outcomes and complications were collected both during hospitalization and follow-up. DRT diagnosis was made by transesophageal echocardiography or CT, and defined as the presence of thrombi adhered to device atrial surface.

Read also: Degenerative Mitral Regurgitation: Impact on Post-Procedural Gradient.

The sample included 1317 patients of mean age 74.9, mostly men. 56% of patients underwent proximal device implantation while the remaining 44% received distal implantation. There were no significant differences in procedural outcomes between the groups.  

Proximal implantation patients saw low DRT rate, vs distal implantation patients (2.3% vs 12.2%; P < 0.001), regardless of device type. There were no significant differences in secondary end point. At multivariable analysis, distal implantation and single antiplatelet treatment or its absence (HR: 1.62; CI del 95%: 0.99-2.62) resulted indented factors of DRT.

Conclusion

This study showed that LAAO device implantation depth impacts DRT incidence, and that proximal implantation is the preferred strategy for patients undergoing this procedure. 

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original Title: Impact of Device Implant Depth After Left Atrial Appendage Occlusion.

Reference: Pedro Cepas-Guillén, MD, PHD et al J Am Coll Cardiol Intv 2023.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...

ACC 2026 | CHAMPION-AF: Left atrial appendage closure versus anticoagulation in atrial fibrillation

Can left atrial appendage closure challenge anticoagulation as the standard of care in atrial fibrillation? Atrial fibrillation (AF) is the most common sustained arrhythmia and...

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...